{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:52:13Z","timestamp":1782957133939,"version":"3.54.5"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate the utility of combining unenhanced and contrast-enhanced CT intratumoral and peritumoral radiomic features with clinical variables for distinguishing benign from malignant parotid gland tumors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively collected clinical and imaging data from 171 patients with pathologically confirmed parotid gland tumors treated at Baoding First Central Hospital between June 2019 and June 2025 (101 benign, 70 malignant). Tumor ROIs were manually delineated slice-by-slice on non-contrast, arterial-phase and venous-phase CT images, and peritumoral regions were automatically expanded by 1\u20134 mm. The cohort was randomly split into training and test sets at a 7:3 ratio. After extraction and selection of radiomic features, multiple models were constructed for intratumoral, various peritumoral ranges (1\u20134 mm) and intratumoral+peritumoral combinations. Model performance was evaluated by ROC curves, the optimal radiomics model was selected and integrated with the clinical model to produce a combined model, and a nomogram was subsequently developed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The AUC values of the intratumoral, peritumoral (1\u20134 mm) and intratumoral+peritumoral models in the training set were 0.966, 0.953, 0.927, 0.983, 0.947, 0.959, 0.956, 0.909 and 0.976, respectively; in the test set the AUCs were 0.797, 0.766, 0.791, 0.714, 0.710, 0.805, 0.836, 0.778 and 0.753, respectively. According to the DeLong test, in the training set the differences between intratumor+peritumor 3mm <jats:italic>vs<\/jats:italic>. peritumor 3mm and between intratumor+peritumor 3mm <jats:italic>vs<\/jats:italic>. intratumor+peritumor 4mm were statistically significant (p = 0.022 and p = 0.026, respectively); in the test set, differences among the models were not statistically significant (P &amp;gt; 0.05). From this, it can be seen the combined intratumoral + 2 mm peritumoral radiomics model demonstrated superior diagnostic performance compared to models based exclusively on either intratumoral or peritumoral features. Consequently, this model was designated as the optimal radiomic signature and was integrated with independent clinical risk factors\u2014specifically symptomatology and tumor margin status\u2014to construct a combined clinical\u2013radiomics predictive model. In the training and test sets, the AUC values of the radiomics model were 0.956 and 0.836, respectively, while those of the clinical model were 0.774 and 0.703. The combined model achieved AUC values of 0.974 and 0.844, demonstrating significantly superior diagnostic performance compared to the standalone clinical or radiomics models, along with the highest clinical utility. According to the Delong test, in the training set the differences between the clinical model and the combined model, and between the clinical model and the radiomics model, were statistically significant (p = 0.000 and p = 0.000, respectively); in the test set, differences among the models were not statistically significant (P &amp;gt; 0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>A multiphase CT radiomics approach that fuses intratumoral features with a 2 mm peritumoral zone robustly distinguishes benign from malignant parotid gland tumors. Integration with key clinical predictors further enhances diagnostic accuracy, supporting clinical translation of the combined model for noninvasive tumor characterization.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1650943","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:19:15Z","timestamp":1758773955000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical value of intratumoral and peritumoral CT radiomics models for discriminating benign and malignant parotid gland tumors"],"prefix":"10.3389","volume":"15","author":[{"given":"Cong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naijing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.otc.2015.10.005","article-title":"Benign parotid tumors","volume":"49","author":"Zhan","year":"2016","journal-title":"Otolaryngol Clin North Am"},{"key":"B2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.17305\/bjbms.2020.5028","article-title":"Cross-sectional imaging and cytologic investigations in the preoperative diagnosis of parotid gland tumors \u2013 an updated literature review","volume":"21","author":"Stoia","year":"2020","journal-title":"Bosn J Basic Med Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjorl.2015.03.007","article-title":"Parotid gland tumors: a retrospective study of 154 patients","volume":"81","author":"Maahs","year":"2015","journal-title":"Braz J Otorhinolaryngol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4329\/wjr.v8.i5.501","article-title":"Biopsy of parotid masses: review of current techniques","volume":"8","author":"Haldar","year":"2016","journal-title":"World J Radiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2005.10.050","article-title":"Acute parotitis as a complication of fine-needle aspiration in Warthin\u2019s tumor. A unique finding of a 3-year experience with parotid tumor aspiration","volume":"134","author":"Bahar","year":"2006","journal-title":"Otolaryngol Neck Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10006-011-0291-8","article-title":"Fine-needle aspiration cytology of salivary gland tumours: a 10-year retrospective analysis","volume":"16","author":"Kechagias","year":"2012","journal-title":"Oral Maxillofac Surg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.21037\/qims.2019.04.11","article-title":"Effects of region of interest sizes on apparent diffusion coefficient measurements of pleomorphic adenoma, Warthin tumor, and normal parotid parenchyma","volume":"9","author":"Sun","year":"2019","journal-title":"Quant Imaging Med Surg"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1259\/dmfr.20130237","article-title":"Diagnostic value of CT perfusion imaging for parotid neoplasms","volume":"43","author":"Dong","year":"2014","journal-title":"Dentomaxillofac Radiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics: the bridge between medical imaging and personalized medicine","volume":"14","author":"Lambin","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00821","article-title":"CT-based radiomics signature for the preoperative discrimination between head and neck squamous cell carcinoma grades","volume":"9","author":"Wu","year":"2019","journal-title":"Front Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00374","article-title":"Radiomics in glioblastoma: current status and challenges facing clinical implementation","volume":"9","author":"Chaddad","year":"2019","journal-title":"Front Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00505","article-title":"Machine learning-based analysis of MR multiparametric radiomics for the subtype classification of breast cancer","volume":"9","author":"Xie","year":"2019","journal-title":"Front Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.943942","article-title":"Nomogram based on CT radiomics features combined with clinical factors to predict Ki-67 expression in hepatocellular carcinoma","volume":"12","author":"Wu","year":"2022","journal-title":"Front Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-07421-4","article-title":"A CT-based radiomics nomogram for differentiation of lympho-associated benign and Malignant lesions of the parotid gland","volume":"31","author":"Zheng","year":"2021","journal-title":"Eur Radiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/mp.16042","article-title":"Development and validation of CT-based radiomics nomogram for the classification of benign parotid gland tumors","volume":"50","author":"Zheng","year":"2023","journal-title":"Med Phys"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2022.06.017","article-title":"Distinguishing parotid polymorphic adenoma and Warthin tumor based on the CT radiomics nomogram: a multicenter study","volume":"30","author":"Feng","year":"2023","journal-title":"Acad Radiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13046-020-01709-5","article-title":"The role of microenvironment in tumor angiogenesis","volume":"39","author":"Jiang","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-022-08830-3","article-title":"CT-based radiomics analysis of different machine learning models for differentiating benign and Malignant parotid tumors","volume":"32","author":"Zheng","year":"2022","journal-title":"Eur Radiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/0194599820932512","article-title":"Controversies in the workup and surgical management of parotid neoplasms","volume":"164","author":"Moore","year":"2021","journal-title":"Otolaryngol Neck Surg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/jmri.27061","article-title":"Multiparametric magnetic resonance imaging for the diagnosis and differential diagnosis of parotid gland tumors","volume":"52","author":"G\u00f6k\u00e7e","year":"2020","journal-title":"J Magn Reson Imaging"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-017-0813-z","article-title":"Assessment of salivary gland tumors using MRI and CT: impact of experience on diagnostic accuracy","volume":"123","author":"Vogl","year":"2018","journal-title":"Radiol Med (Torino)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00255","article-title":"A computed tomography-based radiomic prognostic marker of advanced high-grade serous ovarian cancer recurrence: a multicenter study","volume":"9","author":"Wei","year":"2019","journal-title":"Front Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.937050","article-title":"Differentiation of benign from Malignant parotid gland tumors using conventional MRI based on radiomics nomogram","volume":"12","author":"Qi","year":"2022","journal-title":"Front Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.656918","article-title":"MRI-based radiomics to differentiate between benign and Malignant parotid tumors with external validation","volume":"11","author":"Piludu","year":"2021","journal-title":"Front Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.634452","article-title":"The role of preoperative computed tomography radiomics in distinguishing benign and Malignant tumors of the parotid gland","volume":"11","author":"Xu","year":"2021","journal-title":"Front Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-07483-4","article-title":"MRI-based radiomics nomogram for differentiation of benign and Malignant lesions of the parotid gland","volume":"31","author":"Zheng","year":"2021","journal-title":"Eur Radiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejro.2022.100429","article-title":"Usefulness of MRI-based radiomic features for distinguishing Warthin tumor from pleomorphic adenoma: performance assessment using T2-weighted and post-contrast T1-weighted MR images","volume":"9","author":"Faggioni","year":"2022","journal-title":"Eur J Radiol Open"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-023-01676-9","article-title":"Radiomics under 2D regions, 3D regions, and peritumoral regions reveal tumor heterogeneity in non-small cell lung cancer: a multicenter study","volume":"128","author":"Zhang","year":"2023","journal-title":"Radiol Med (Torino)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1042\/CS20210679","article-title":"Interrelationships between the extracellular matrix and the immune microenvironment that govern epithelial tumour progression","volume":"136","author":"Kolesnikoff","year":"2022","journal-title":"Clin Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04015-z","article-title":"Intratumoral and peritumoral CT-based radiomics strategy reveals distinct subtypes of non-small-cell lung cancer","volume":"148","author":"Tang","year":"2022","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13244-024-01855-w","article-title":"Intratumoral and peritumoral MRI-based radiomics for predicting extrapelvic peritoneal metastasis in epithelial ovarian cancer","volume":"15","author":"Wang","year":"2024","journal-title":"Insights Imaging"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.848846","article-title":"Differentiation of Malignant brain tumor types using intratumoral and peritumoral radiomic features","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-07948-0","article-title":"The value of various peritumoral radiomic features in differentiating the invasiveness of adenocarcinoma manifesting as ground-glass nodules","volume":"31","author":"Wu","year":"2021","journal-title":"Eur Radiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.62347\/AXQW1100","article-title":"Preoperative CT-based intra- and peri-tumoral radiomic models for differentiating benign and Malignant tumors of the parotid gland: a two-center study","volume":"14","author":"Shen","year":"2024","journal-title":"Am J Cancer Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1650943\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:19:15Z","timestamp":1758773955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1650943\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":34,"alternative-id":["10.3389\/fonc.2025.1650943"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1650943","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"article-number":"1650943"}}